KIM HEIM: Open Payments
NPI 1548602154 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 16 payments from 9 companies in 2025. Trend: 2023 $392 · 2024 $145 · 2025 $491
Food & beverage: $305Education: $186
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $186 |
| Caris MPI, Inc. | 3 | $53 |
| Eisai Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $42 |
| Legend Biotech USA Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Genmab U.S., Inc. | 1 | $24 |
Products named: MI CANCER SEEK, Lenvima, ELAHERE, TALVEY, CARVYKTI, KEYTRUDA, KISQALI, Tivdak.
Industry payments across OH — which companies pay providers there.
